Industrial conglomerate Crane (NYSE:CR) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 9.3% year on year to $557.6 million. Its non-GAAP profit of $1.39 per share was 6.9% above analysts’ consensus estimates.

Is now the time to buy CR? Find out in our full research report (it’s free).

  • Revenue: $557.6 million vs analyst estimates of $549.1 million (9.3% year-on-year growth, 1.5% beat)

  • Adjusted EPS: $1.39 vs analyst estimates of $1.31 (6.9% beat)

  • Adjusted EBITDA: $116.6 million vs analyst estimates of $114.9 million (20.9% margin, 1.5% beat)

  • Management reiterated its full-year Adjusted EPS guidance of $5.45 at the midpoint

  • Operating Margin: 18.1%, up from 15.9% in the same quarter last year

  • Free Cash Flow was -$60.4 million compared to -$89 million in the same quarter last year

  • Organic Revenue rose 7.5% year on year (5% in the same quarter last year)

  • Market Capitalization: $9.75 billion

Crane’s first quarter results reflected solid execution in its core segments, with management highlighting notable growth across both Aerospace & Electronics and Process Flow Technologies. CEO Max Mitchell credited the company’s business system and disciplined operational execution for driving 7.5% core sales growth, emphasizing that “strength across both Aerospace & Electronics and Process Flow Technologies” supported the quarter. Management pointed to strong performance in commercial aftermarket sales and strategic wins in defense programs as key contributors to order momentum.

Looking ahead, Crane’s leadership reaffirmed its full-year adjusted EPS guidance, citing confidence in the company’s ability to navigate macroeconomic uncertainty, including evolving tariff policies and supply chain conditions. COO Alex Alcala detailed the company’s strategies to offset tariff impacts, such as pricing actions and productivity improvements, and stressed that investments in new product development and acquisitions remain central to Crane’s growth plan. CFO Rich Maue added that the company’s robust backlog and healthy balance sheet provide flexibility to pursue acquisitions even as external pressures persist.

Management focused on how the company’s diversified end markets, operational discipline, and backlog growth positioned Crane for continued performance. The primary deviation from consensus expectations stemmed from stronger-than-anticipated Aerospace & Electronics orders.

  • Aerospace Aftermarket Momentum: Commercial and military aftermarket demand remained elevated, with management reporting ongoing strong procurement activity and limited signs of fleet retirement. This helped sustain double-digit growth in aftermarket sales for a sixteenth consecutive quarter.

  • Defense Program Wins: Crane secured new content on major defense platforms, including the XM30 optionally manned fighting vehicle and Bell V-280, as well as engineering contracts for unmanned aviation. These wins are expected to support growth throughout the decade.

  • Process Flow Technologies Portfolio Shift: Management discussed continued portfolio realignment toward higher-growth sectors like pharmaceuticals, water, and cryogenics, with recent wins including pharmaceutical valve approvals and significant projects in the Middle East.

  • Tariff Exposure Management: Leadership detailed that 7%–8% of cost of goods sold comes from direct imports, primarily affecting Process Flow Technologies. While tariffs represent a $60 million gross headwind for 2025, Crane expects to offset most of the impact through price increases and productivity gains.

  • M&A Pipeline Remains Active: CEO Max Mitchell and COO Alex Alcala both emphasized ongoing due diligence across multiple acquisition targets. The company’s net cash position and $1.5 billion in debt capacity provide ample resources to pursue both small and larger deals this year.